Nateglinide [nateglinid]
- Terms
-
Starlix
-
A 4166
A-4166
AY 4166
AY-4166
DJN 608
Fastic
N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine
Nate-Glinide
Nateglinide, (cis,D-Phe)-isomer
Nateglinide, (D-Phe)-isomer
Senaglinide
Starlix
Starsis
A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.
- DUI
- D000077715 MeSH Browser
- CUI
- M0353981
- CAS
- D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
- History note
- 2019 (1989)
- Public note
- 2019; NATEGLINIDE was indexed under PHENYLALANINE/analogs & derivatives and CYCLOHEXANES 1989-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine